Skip to content

Wayfinder: Assessing the effectiveness of a navigation rehabilitation training

Wayfinder: Assessing the effectiveness of a navigation rehabilitation training - Wayfinder-NRT

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46611
Enrollment
64
Registered
2018-05-28
Start date
2018-06-11
Completion date
Unknown
Last updated
2024-06-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

navigation impairment topographical disorientation

Interventions

The navigation rehabilitation training consists of a psycho-education session and individual training sessions using the Wayfinder software, a serious-gaming eHealth application which is installed o

Sponsors

Universiteit Leiden
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Report navigation impairments after acquired brain injury.;Clinically diagnosed acquired brain injury.;Non-acute phase of the brain injury (> 6 months post event).;PC of Mac computer at home with internet access.;18-85 years of age.;Sufficient motivation to use the intervention for 6 weeks.;Sufficient comprehension and communication to partake in the intervention.;Written informed consent.

Exclusion criteria

Exclusion criteria: Physically and/or mentally unable to participate;Known spatial neglect, diagnosed clinically with neuropsychological neglect test (Line Bisection test or cancellation task);Interfering psychiatric disorder (dementia, depression, anxiety disorder, schizophrenia, autism, obsessive compulsive disorder, personality disorder etc.) or substance abuse.;Non-Dutch speaking

Design outcomes

Primary

MeasureTime frame
A decrease in self-reported navigation complaints, measured with the Wayfinding questionnaire

Secondary

MeasureTime frame
An increase in objective navigation performance, measured with the Virtual Tübingen test.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)